Clinical Trials Browser

Phase 2 × hetrombopag × 90 days × Clear all

NCT07408648 2026-02-13

A Clinical Study on the Efficacy and Safety of Hetrombopag in the Treatment of Thrombocytopenia Induced by Gynecological Tumor Therapy

Phase 2 Not yet recruiting

Classical hematology

Chemotherapy Induced Thrombocytopenia

NCT07334093 2026-01-12

A Study of Hetrombopag Combined With rhTPO in the Treatment of Cancer Therapy-induced Thrombocytopenia (CTIT) in Solid Tumor Patients.

Phase 2 Not yet recruiting

Classical hematology

Cancer Therapy-induced Thrombocytopenia (CTIT)